158 related articles for article (PubMed ID: 34151267)
1. An integrative analysis of genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA detects noninvasive diagnostic markers for gliomas.
Cai J; Zeng C; Hua W; Qi Z; Song Y; Lu X; Li D; Zhang Z; Cui X; Zhang X; Yang Z; Zhang J; Quan K; Zhu W; Cai J; He C; Cheng SY; Zhang W; Mao Y
Neurooncol Adv; 2021; 3(1):vdab049. PubMed ID: 34151267
[TBL] [Abstract][Full Text] [Related]
2. Alterations of 5-hydroxymethylcytosines in circulating cell-free DNA reflect retinopathy in type 2 diabetes.
Han L; Chen C; Lu X; Song Y; Zhang Z; Zeng C; Chiu R; Li L; Xu M; He C; Zhang W; Duan S
Genomics; 2021 Jan; 113(1 Pt 1):79-87. PubMed ID: 33221518
[TBL] [Abstract][Full Text] [Related]
3. Dissection of transcriptomic and epigenetic heterogeneity of grade 4 gliomas: implications for prognosis.
Zeng C; Song X; Zhang Z; Cai Q; Cai J; Horbinski C; Hu B; Cheng SY; Zhang W
Acta Neuropathol Commun; 2023 Aug; 11(1):133. PubMed ID: 37580817
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive detection of brain gliomas using plasma cell-free DNA 5-hydroxymethylcytosine sequencing.
Zhang S; Zhang J; Hu X; Yin S; Yuan Y; Xia L; Cao F; Yan X; Yan Z; Mao Q; Xie D; Liu Y
Int J Cancer; 2023 Apr; 152(8):1707-1718. PubMed ID: 36522844
[TBL] [Abstract][Full Text] [Related]
5. A 5-hydroxymethylcytosine-based non-invasive model for early detection of colorectal carcinomas and advanced adenomas: the METHOD-2 study.
Chang W; Zhang Z; Jia B; Ding KF; Pan Z; Su G; Zhang W; Liu T; Zhong Y; He G; Ren L; Wei Y; Li D; Cui X; Yang J; Shi Y; Bissonnette M; He C; Zhang W; Fan J; Xu J
Clin Cancer Res; 2024 May; ():. PubMed ID: 38814264
[TBL] [Abstract][Full Text] [Related]
6. Cell-free DNA 5-hydroxymethylcytosine profiles of long non-coding RNA genes enable early detection and progression monitoring of human cancers.
Zhou M; Hou P; Yan C; Chen L; Li K; Wang Y; Zhao J; Su J; Sun J
Clin Epigenetics; 2021 Oct; 13(1):197. PubMed ID: 34689838
[TBL] [Abstract][Full Text] [Related]
7. Machine learning identifies cell-free DNA 5-hydroxymethylation biomarkers that detect occult colorectal cancer in PLCO Screening Trial subjects.
West-Szymanski DC; Zhang Z; Cui XL; Kowitwanich K; Gao L; Deng Z; Dougherty U; Williams C; Merkle S; Moore M; He C; Bissonnette M; Zhang W
bioRxiv; 2024 Feb; ():. PubMed ID: 38464122
[TBL] [Abstract][Full Text] [Related]
8. Analysis of genome-wide 5-hydroxymethylation of blood samples stored in different anticoagulants: opportunities for the expansion of clinical resources for epigenetic research.
Gao L; Zhang Z; Cui XL; West-Szymanski D; Ye C; He C; Zhang W; Bissonnette M
Epigenetics; 2023 Dec; 18(1):2271692. PubMed ID: 37898998
[TBL] [Abstract][Full Text] [Related]
9. 5-Hydroxymethylcytosines in Circulating Cell-Free DNA Reveal Vascular Complications of Type 2 Diabetes.
Yang Y; Zeng C; Lu X; Song Y; Nie J; Ran R; Zhang Z; He C; Zhang W; Liu SM
Clin Chem; 2019 Nov; 65(11):1414-1425. PubMed ID: 31575611
[TBL] [Abstract][Full Text] [Related]
10. 5-Hydroxymethylcytosines in circulating cell-free DNA reveal a diagnostic biomarker for glioma.
Zhang C; Zhou W; Tan Y; Tian D; Zhong C
Heliyon; 2022 Oct; 8(10):e11022. PubMed ID: 36281400
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide Analysis Reflects Novel 5-Hydroxymethylcytosines Implicated in Diabetic Nephropathy and the Biomarker Potential.
Yang Y; Zeng C; Yang K; Xu S; Zhang Z; Cai Q; He C; Zhang W; Liu SM
Extracell Vesicles Circ Nucl Acids; 2022; 3(1):49-60. PubMed ID: 35342902
[TBL] [Abstract][Full Text] [Related]
12. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic and predictive biomarkers for coronary artery disease.
Dong C; Chen J; Zheng J; Liang Y; Yu T; Liu Y; Gao F; Long J; Chen H; Zhu Q; He Z; Hu S; He C; Lin J; Tang Y; Zhu H
Clin Epigenetics; 2020 Jan; 12(1):17. PubMed ID: 31964422
[TBL] [Abstract][Full Text] [Related]
13. Integrated 5-hydroxymethylcytosine and fragmentation signatures as enhanced biomarkers in lung cancer.
Hu X; Luo K; Shi H; Yan X; Huang R; Zhao B; Zhang J; Xie D; Zhang W
Clin Epigenetics; 2022 Jan; 14(1):15. PubMed ID: 35073982
[TBL] [Abstract][Full Text] [Related]
14. Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma.
Cai Z; Zhang J; He Y; Xia L; Dong X; Chen G; Zhou Y; Hu X; Zhong S; Wang Y; Chen H; Xie D; Liu X; Liu J
ESMO Open; 2021 Feb; 6(1):100021. PubMed ID: 33508734
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma.
Chiu BC; Zhang Z; You Q; Zeng C; Stepniak E; Bracci PM; Yu K; Venkataraman G; Smith SM; He C; Zhang W
Blood Adv; 2019 Oct; 3(19):2790-2799. PubMed ID: 31570490
[TBL] [Abstract][Full Text] [Related]
16. Considerations before the application of 5-hydroxymethylation levels of long non-coding RNAs for non-invasive cancer diagnosis.
Zhang Z; Zeng C; Zhang W
Extracell Vesicles Circ Nucl Acids; 2022; 3(1):10-13. PubMed ID: 35098258
[TBL] [Abstract][Full Text] [Related]
17. Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer's Disease.
Beadell AV; Zhang Z; Capuano AW; Bennett DA; He C; Zhang W; Arvanitakis Z
J Alzheimers Dis; 2023; 93(3):1135-1151. PubMed ID: 37182870
[TBL] [Abstract][Full Text] [Related]
18. 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease.
Chen L; Shen Q; Xu S; Yu H; Pei S; Zhang Y; He X; Wang Q; Li D
J Alzheimers Dis; 2022; 85(2):573-585. PubMed ID: 34864677
[TBL] [Abstract][Full Text] [Related]
19. PETCH-DB: a Portal for Exploring Tissue-specific and Complex disease-associated 5-Hydroxymethylcytosines.
Cai Q; Zhang Z; Cui X; Zeng C; Cai J; Cai J; Wu K; Zhang X; Shi Y; Arvanitakis Z; Bissonnette MA; Chiu BC; Cheng SY; He C; Zhang W
Database (Oxford); 2023 Jun; 2023():. PubMed ID: 37387524
[TBL] [Abstract][Full Text] [Related]
20. 5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnostic factor for early-stage colorectal cancer and precancerous adenoma.
Xiao Z; Wu W; Wu C; Li M; Sun F; Zheng L; Liu G; Li X; Yun Z; Tang J; Yu Y; Luo S; Sun W; Feng X; Cheng Q; Tao X; Wu S; Tao J
Mol Oncol; 2021 Jan; 15(1):138-150. PubMed ID: 33107199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
